BSEFortis Malar Hospitals Ltd· Healthcare ServicesHighNegative
Announced Wed, 24 Dec, 2025 · 18:46 IST

The relevant disclosure is attached.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹59.80
prior close
₹61.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+0.7% vs market
Hospital peers, median of 22sector-0.7%+0.8% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 0.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
+0.2
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2-0.5+0.7-0.7+0.8
Next day
-4.1-1.3-2.8-1.5-2.6
2d
-3.0-1.4-1.7-1.9-1.1
3d
-2.2+0.0-2.2-1.5-0.7
4d
-0.4+0.2-0.7-0.5+0.1
5d
+0.3+1.2-0.8+0.5-0.2
1w
-0.4+0.8-1.2-0.8+0.3
15d
-4.7-5.1+0.4-5.8+1.1
1m
-8.6-8.8+0.2-10.9+2.4
2m
-9.5-4.5-5.1-11.3+1.7
3m
-22.2-13.7-8.6-15.5-6.7
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fortis Malar Hospitals has disclosed receiving an Income Tax Order dated December 24, 2025, from the Centralized Processing Centre (CPC), Income Tax Department, Bengaluru. The order was issued under Section 143(1) of the Income Tax Act for Assessment Year 2024-25, raising a demand of INR 20.82 Lakhs. The company is evaluating all options, including filing an appeal against the order. The demand relates to the processing of the company's Return of Income and is a routine tax intimation order rather than a major enforcement action.

Likely market impact

The financial impact is minimal at INR 20.82 Lakhs (roughly ₹20.8 lakh), which is immaterial relative to the company's size. Shareholders are unlikely to see any meaningful impact on the stock price, though the company will incur some legal/advisory costs if it chooses to appeal.